GSK Faces Lengthy Court Battle In UK Over Diabetes Drug
From ValueWalk
January 30, 2013 - 12:02pm
Glaxosmithkline plc (ADR) (NYSE:GSK) could face a lengthy court battle against families in United Kingdom seeking compensation for damages caused by its now withdrawn diabetes drug, Avandia, according to a report from Reuters.
…
Express Solicitors, a law firm based inThe post GSK Faces Lengthy Court Battle In UK Over Diabetes Drug appeared first on ValueWalk.
Continue reading this article »Share This Article: